Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray for perioperative sleep quality in elderly patients undergoing laparoscopic tumor resection
ChiCTR2200065202Phase 4Not yet recruiting
- Sponsor
- Beijing Hospital
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in perioperative sleep disturbance (2 arms), sponsored by Beijing Hospital. Primary endpoint: Quality of sleep on the night of surgery. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
perioperative sleep disturbance
Beyond the preview
Go deeper on ChiCTR2200065202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065202.